Uploaded August 2026 | Updated September 2026, 2 weeks ago

---

When Duncan Ross — one of the most respected voices in exosome science — set a potency standard, it reframed how we should evaluate every product on the market.

Dr. Edward Park breaks down the RNA vs. protein debate in exosome potency standards and why this distinction is critical for providers sourcing products and patients evaluating outcomes.

Watch full episode: youtu.be/qyQz7fN5JJo
💊 Get 10% off TA-65: rechargebiomedical.com/ta-65 (code: recharge10)
📅 Book a free consultation: rechargebiomedical.com/contact-us
🧪 10% off Zeolite Labs: zeolitelabs.com (code: recharge10)

⚠️ DISCLAIMER: This content is for educational purposes only and does not constitute medical advice or product endorsement. Exosome therapies are investigational. Always consult a licensed healthcare provider. Individual results may vary.


#drpark #dredpark #drpark65 #exosomes #exosomepotency #RNAtherapy #regenerativemedicine #exosometherapy #stemcells #antiaging #longevity #rechargeBiomedical #biohacking